None listed
Conditions
Interventions
Intervention1: Anti Pimple Face Oil (B. No- BO242163): Subjects will wash their hands properly before application of the product. Before every application the subject will wash their face with the pro
Sponsors
Eliea Wellness Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: Healthy male & female subjects in the age group of 18-45 years (both age inclusive) Subject is having valid proof of identity and age Subject is having apparently healthy skin on test area Subjects must have a facial acne score of 1to 2 (For Group A) that will be clinically determined to be mild and a score of 2 to 3 (Group B) clinically determined to be clinically to be mild to moderate. Subjects having 1- 3 inflammatory active lesions for (Group A) and 3-10 inflammatory active lesions (For Group B). No treatment for acne/facial in the past 1 month. Subjects willing to give voluntary written informed consent. Subjects willing to come for regular follow up visits Subjects ready to follow instructions during the study period Subjects without any open wounds, cuts, abrasions, irritation symptoms on test area. Subject willing to perform UPT (for females only).
Exclusion criteria
Exclusion criteria: Subjects with Known hypersensitivity to any of the study products or constituents Subjects who is using any oral or topical prescription or over-the-counter (OTC) acne treatments (and topical retinoids) within the past 30 days Dark spots and post acne scars on the test area. Subjects with any kind of skin allergy, antecedents or cutaneous disease or any significant pathology in the test area which may influence the study results. Subjects having topical or systemic treatment in last month prior to participation in the study and during the study that could interfere with the study treatments/ assessments Subject is Pregnant or Lactating Subject with any significant medical condition that would interfere with the participation in the trial Subjects participated in any other cosmetic or therapeutic trial or in a similar investigation Subject is having Scars, excessive terminal hair or tattoos on the test area.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visible reduction in acne appearance at Day 3 (For Group A) & at Day 20 (For Group B) Notable reduction in the lesion count, specifically in the number of papules and pustules Assessment of lesion size, skin smoothness, overall redness of inflammatory lesions, overall size of inflammatory lesions, comedogenic potential of the test product. Percentage of subjects who achieved full relief from facial acne at Day 3 (For Group A) & at Day 20 (For Group B). Timepoint: Group A Day 0 Day 1 Day 3 Group B Day 0 Day 10 Day 20 | — |
Secondary
| Measure | Time frame |
|---|---|
| • Safety & Tolerability of the investigational product during the entire study duration of 3 Days (For Group A) & 20 Days (For Group B)Timepoint: Group A Day 0 Day 1 Day 3 Group B Day 0 Day 10 Day 20 | — |
Countries
India
Contacts
Public ContactDr Karishma Kapoor
Auriga Research Private Limited
Outcome results
None listed